ABLATE WEIGHT 2 (Single-Stage Fundic Ablation Plus ESG for Weight Loss)
Public ClinicalTrials.gov record NCT05992103. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Single-Stage Gastric Fundus Ablation and Endoscopic Sleeve Gastroplasty for Weight Loss
Study identification
- NCT ID
- NCT05992103
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- True You Weight Loss
- Other
- Enrollment
- 10 participants
Conditions and interventions
Conditions
Interventions
- Fundic Ablation in Combination with Endoscopic Sleeve Gastroplasty Procedure
- Fundic Mucosal Ablation with ERBE HybridAPC Device
- Apollo ESG Device
Procedure · Device
Eligibility (public fields only)
- Age range
- 21 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 13, 2023
- Primary completion
- Apr 13, 2025
- Completion
- May 14, 2025
- Last update posted
- Dec 6, 2023
2023 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| True You Weight Loss | Cary | North Carolina | 27513 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05992103, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2023 · Synced Jun 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05992103 live on ClinicalTrials.gov.